SARS-CoV-2 Viral Genome Sequencing Data Presented from Research Using Pacific Biosciences Technology
December 16, 2020 08:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes,...
Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads
December 14, 2020 08:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes,...
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
November 11, 2020 00:21 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its...
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
November 10, 2020 16:05 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of its common...
Pacific Biosciences of California, Inc. Announces Third Quarter 2020 Financial Results
November 02, 2020 16:02 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2020. ...
Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics
October 22, 2020 08:00 ET
|
Pacific Biosciences of California, Inc.
SAN FRANCISCO and MENLO PARK, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a...
Pacific Biosciences of California, Inc. Third Quarter 2020 Financial Results Call
October 19, 2020 12:30 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2020 Financial...
Children’s Mercy Kansas City Teams Up with Pacific Biosciences to Fight Rare Disease
October 15, 2020 08:00 ET
|
Pacific Biosciences of California, Inc.; Children’s Mercy Kansas City
KANSAS CITY, Mo., and MENLO PARK, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Children’s Mercy Kansas City, one of the nation’s top pediatric medical systems, and Pacific Biosciences of California,...
Pacific Biosciences Launches the Sequel IIe System to Accelerate Adoption of Highly Accurate HiFi Sequencing
October 05, 2020 08:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes,...
Pacific Biosciences Announces New Chief Financial Officer
September 14, 2020 09:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and...